Compounds > tert-butylhydroperoxide
Page last updated: 2024-08-17

tert-butylhydroperoxide and 6-ketoprostaglandin f1 alpha

tert-butylhydroperoxide has been researched along with 6-ketoprostaglandin f1 alpha in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19904 (66.67)18.7374
1990's2 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chakraborti, S; Gurtner, GH; Michael, JR1
Adkinson, NF; Farrukh, IS; Freeland, HS; Gurtner, GH; Michael, JR; Paky, A; Peters, SP; Sciuto, AM; Spannhake, EW; Summer, WR1
Adkinson, NF; Gurtner, GH; Sciuto, AM; Shayevitz, JR; Traystman, RJ1
Adkinson, NF; Gurtner, GH; Knoblauch, A; Sies, H; Smith, PL1
Jesse, R; Walsh, SW; Wang, Y1
Romney, AD; Walsh, MD; Walsh, SW; Wang, Y1

Other Studies

6 other study(ies) available for tert-butylhydroperoxide and 6-ketoprostaglandin f1 alpha

ArticleYear
Oxidant-mediated activation of phospholipase A2 in pulmonary endothelium.
    The American journal of physiology, 1989, Volume: 257, Issue:6 Pt 1

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acid; Arachidonic Acids; Aspirin; Calcium; Calcium Channel Blockers; Cattle; Cells, Cultured; Cycloheximide; Dactinomycin; Dexamethasone; Dinoprostone; Egtazic Acid; Endothelium, Vascular; Enzyme Activation; Kinetics; Peroxides; Phospholipases; Phospholipases A; Phospholipases A2; Prostaglandin D2; Pulmonary Artery; tert-Butylhydroperoxide; Thromboxane B2; Vitamin E

1989
The role of cyclooxygenase and lipoxygenase mediators in oxidant-induced lung injury.
    The American review of respiratory disease, 1988, Volume: 137, Issue:6

    Topics: 5,8,11,14-Eicosatetraynoic Acid; 6-Ketoprostaglandin F1 alpha; Animals; Blood Pressure; Chromones; Free Radicals; Indomethacin; Leukotrienes; Lipoxygenase; Lung; Lung Diseases; Male; Organ Size; Oxygen; Peroxides; Prostaglandin-Endoperoxide Synthases; Pulmonary Artery; Rabbits; tert-Butylhydroperoxide; Thromboxane B2

1988
Inhalation anesthetics augment oxidant-induced pulmonary vasoconstriction: evidence for a membrane effect.
    Anesthesiology, 1985, Volume: 63, Issue:6

    Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Anesthesia, Inhalation; Anesthetics; Animals; Arachidonic Acids; Blood Pressure; Cell Membrane; Cyclooxygenase Inhibitors; Halothane; In Vitro Techniques; Indomethacin; Male; Peroxides; Pulmonary Artery; Pulmonary Circulation; Rabbits; tert-Butylhydroperoxide; Thromboxane B2; Vasoconstriction

1985
Oxidant- and lipid-induced pulmonary vasoconstriction mediated by arachidonic acid metabolites.
    Journal of applied physiology: respiratory, environmental and exercise physiology, 1983, Volume: 55, Issue:3

    Topics: 6-Ketoprostaglandin F1 alpha; Animals; Arachidonic Acids; Blood Pressure; Fat Emulsions, Intravenous; Lung; Peroxides; Pulmonary Circulation; Rabbits; tert-Butylhydroperoxide; Thromboxane B2; Vasoconstriction; Vitamin E Deficiency

1983
Peroxide induces vasoconstriction in the human placenta by stimulating thromboxane.
    American journal of obstetrics and gynecology, 1993, Volume: 169, Issue:4

    Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Aspirin; Female; Humans; Organ Culture Techniques; Oxidants; Peroxides; Placenta; Pregnancy; tert-Butylhydroperoxide; Thromboxane B2; Vasoconstriction

1993
Magnesium sulfate attenuates peroxide-induced vasoconstriction in the human placenta.
    American journal of obstetrics and gynecology, 1998, Volume: 178, Issue:1 Pt 1

    Topics: 6-Ketoprostaglandin F1 alpha; Adolescent; Adult; Calcium; Drug Interactions; Epoprostenol; Female; Humans; Magnesium Sulfate; Muscle, Smooth, Vascular; Peroxides; Phospholipases A; Placenta; Pregnancy; tert-Butylhydroperoxide; Thromboxanes; Time Factors; Vasoconstriction

1998